EU Embryo Patent Ban Covers Stem Cells: Court Adviser

Law360, New York (March 10, 2011, 7:50 PM EST) -- Stem cells that can develop into a human embryo and tissue-specific cells created by destroying or modifying an embryo should not be patentable under European Union law, an adviser to the bloc's highest court said Thursday.

In a nonbinding opinion, Advocate General M. Yves Bot urged the European Court of Justice to rule that an EU ban on patenting human embryos should also cover so-called totipotent cells, which are capable of producing any part of an embryo.

He further suggested that pluripotent cells, stem cells which...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.